The Role of Duloxetine in the Treatment of Depression and Associated Painful Physical Symptoms

Por Wohlreich, Madelaine M., Watkin, John G.
Publicado em 2003

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

Por Wohlreich, Madelaine M, Mallinckrodt, Craig H, Watkin, John G, Hay, Donald P
Publicado em 2004

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features

Por Mallinckrodt, Craig H, Watkin, John G, Liu, Chaofeng, Wohlreich, Madelaine M, Raskin, Joel
Publicado em 2005

The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

Por Mallinckrodt, Craig H, Raskin, Joel, Wohlreich, Madelaine M, Watkin, John G, Detke, Michael J
Publicado em 2004

Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting doses

Por Dunner, David L., Wohlreich, Madelaine M., Mallinckrodt, Craig H., Watkin, John G., Fava, Maurizio
Publicado em 2005

Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy.

Por Bailey, Rahn K., Mallinckrodt, Craig H., Wohlreich, Madelaine M., Watkin, John G., Plewes, John M.
Publicado em 2006

Duloxetine in the treatment of major depressive disorder: an open-label study

Por Hudson, James I, Perahia, David G, Gilaberte, Inmaculada, Wang, Fujun, Watkin, John G, Detke, Michael J
Publicado em 2007

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

Por Mallinckrodt, Craig H., Goldstein, David J., Detke, Michael J., Lu, Yili, Watkin, John G., Tran, Pierre V.
Publicado em 2003